Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2025
Clinical outcomes and predictive factors for stent patency in malignant duodenojejunal obstruction: comparison of distal duodenum and proximal jejunum.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Ho Seung, So Hoonsub, Lee Yoonchan, Cho Sung Hyun, Huh Gunn, Song Tae Jun, Seo Dong-Wan, Oh Dongwook
Аннотация
BACKGROUND: Endoscopic self-expandable metal stents (SEMSs) provide a minimally invasive treatment for malignant duodenal obstructions. However, data on stenting of the distal duodenum and proximal jejunum are limited. Therefore, this study aimed to evaluate stent patency and survival outcomes in patients who underwent SEMS placement for distal duodenal (DD) and proximal jejunal (PJ) obstructions.
METHODS: This retrospective cohort study included 73 patients who underwent SEMS placement for malignant duodenojejunal obstruction. The clinical success and procedural outcomes were analyzed. Stent patency and overall survival were analyzed using survival analyses, including Cox proportional hazards modeling.
RESULTS: The technical and clinical success rates were 98.6% and 86.3%, respectively. The median stent patency time was 276.0 days (95% CI, 226.0-482.0), and the median overall survival after stenting was 127.0 days (95% CI, 69.0-201.0). Poststenting chemotherapy was significantly associated with prolonged stent patency (hazard ratio, 0.16; P =.005), whereas stent type was not a significant predictor. Stent dysfunction occurred in 42.5% of patients, primarily due to tumor ingrowth (34.2%).
CONCLUSION: Endoscopic DD and PJ stenting for malignant obstructions demonstrated high technical success and clinical efficacy. Poststenting chemotherapy was associated with prolonged stent patency. Despite a relatively high dysfunction rate, endoscopic SEMSs may be an effective palliative option.
METHODS: This retrospective cohort study included 73 patients who underwent SEMS placement for malignant duodenojejunal obstruction. The clinical success and procedural outcomes were analyzed. Stent patency and overall survival were analyzed using survival analyses, including Cox proportional hazards modeling.
RESULTS: The technical and clinical success rates were 98.6% and 86.3%, respectively. The median stent patency time was 276.0 days (95% CI, 226.0-482.0), and the median overall survival after stenting was 127.0 days (95% CI, 69.0-201.0). Poststenting chemotherapy was significantly associated with prolonged stent patency (hazard ratio, 0.16; P =.005), whereas stent type was not a significant predictor. Stent dysfunction occurred in 42.5% of patients, primarily due to tumor ingrowth (34.2%).
CONCLUSION: Endoscopic DD and PJ stenting for malignant obstructions demonstrated high technical success and clinical efficacy. Poststenting chemotherapy was associated with prolonged stent patency. Despite a relatively high dysfunction rate, endoscopic SEMSs may be an effective palliative option.